Literature DB >> 16711400

Problem areas and inconsistencies in the WHO classification of thymoma.

Saul Suster1, Cesar A Moran.   

Abstract

The morphologic classification of thymoma has undergone numerous revisions in recent years and has been under continuous debate for the past several decades. With the introduction of the World Health Organization (WHO) schema for the classification of thymic epithelial neoplasms in 1999, a major step was taken toward achieving uniformity in the nomenclature of these tumors. A more recent iteration of the WHO morphologic classification of thymic epithelial neoplasms has now been published. Although these efforts have certainly contributed to clarifying many issues related to the pathology of thymoma, several problem areas and inconsistencies still remain surrounding this proposed schema. The purpose of this review is to address these problem areas, in particular as it relates to terminology, histopathologic criteria for diagnosis, and the prognostic significance for the various categories of the WHO schema.

Entities:  

Mesh:

Year:  2005        PMID: 16711400     DOI: 10.1053/j.semdp.2006.02.004

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  11 in total

1.  Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Authors:  Hyun-Sung Lee; Hee-Jin Jang; Rohan Shah; David Yoon; Masatsugu Hamaji; Ori Wald; Ju-Seog Lee; David J Sugarbaker; Bryan M Burt
Journal:  Clin Cancer Res       Date:  2017-04-11       Impact factor: 12.531

2.  The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Authors:  Cesar A Moran; Saul Suster
Journal:  Curr Treat Options Oncol       Date:  2009-02-04

3.  Micronodular thymoma with lymphoid stroma in a multilocular thymic cyst: a case study.

Authors:  Na Rae Kim; Jae Ik Lee; Seung Yeon Ha
Journal:  Korean J Pathol       Date:  2013-08-26

4.  Doubling time of thymic epithelial tumours on CT: correlation with histological subtype.

Authors:  Jooae Choe; Sang Min Lee; Soyeoun Lim; Se Hoon Choi; Namkug Kim; Kyung-Hyun Do; Joon Beom Seo
Journal:  Eur Radiol       Date:  2017-03-22       Impact factor: 5.315

5.  Reproducibility of the WHO classification of thymomas: practical implications.

Authors:  P A Zucali; L Di Tommaso; I Petrini; S Battista; H S Lee; M Merino; E Lorenzi; E Voulaz; F De Vincenzo; M Simonelli; M Roncalli; L Giordano; M Alloisio; A Santoro; G Giaccone
Journal:  Lung Cancer       Date:  2012-12-29       Impact factor: 5.705

Review 6.  Diagnosis of thymoma.

Authors:  S Suster
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

7.  Atypical thymomas with squamoid and spindle cell features: clinicopathologic, immunohistochemical and molecular genetic study of 120 cases with long-term follow-up.

Authors:  David I Suster; A Craig Mackinnon; Marcello DiStasio; Malay Kumar Basu; German Pihan; Saul Suster
Journal:  Mod Pathol       Date:  2022-02-10       Impact factor: 8.209

8.  Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.

Authors:  Noriaki Sakakura; Hisashi Tateyama; Shigeo Nakamura; Tetsuo Taniguchi; Noriyasu Usami; Yoshinori Ishikawa; Koji Kawaguchi; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-12

Review 9.  The enlightenments from ITMIG Consensus on WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Authors:  Jie Wu; Wentao Fang; Gang Chen
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

10.  Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.

Authors:  Yusuke Okuma; Yukio Hosomi; Kageaki Watanabe; Yuko Yamada; Hirotoshi Horio; Yoshiharu Maeda; Tatsuru Okamura; Tsunekazu Hishima
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.